Skip to main content
Show full summary

Baroness Finlay of Llandaff to ask Her Majesty's Government why the use of Ronapreve has been restricted only to people who are currently hospitalised with COVID-19; what assessment they have made of the numbers of patients expected to be treated with Ronapreve in the next 12 months; and what, if any assessment, they have made of the benefits of providing it as prophylaxis for high-risk patients who are not in hospital.  HL2921

Question HL2921: tabled on 11 October 2021 and due for answer by 25 October 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

To ask Her Majesty's Government why the use of Ronapreve has been restricted only to people who are currently hospitalised with COVID-19; what assessment they have made of the numbers of patients expected to be treated with Ronapreve in the next 12 months; and what, if any assessment, they have made of the benefits of providing it as prophylaxis for high-risk patients who are not in hospital.
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.